Future studies should investigate whether IPMK deletion directly impacts Elk-1 activity in skeletal muscle and how this contributes to the metabolic phenotypes observed, including insulin resistance and altered lipid metabolism. This evidence concerns the gene ELK1 and Insulin resistance.